Oncurie, LLC

Oncurie, LLC, based in Raleigh, NC, is at the forefront of radiopharmaceutical innovation, developing novel chelators that explore new regions of the periodic table for cancer treatment. The company is particularly focused on ovarian cancer, having created a unique compound that delivers radioisotopes to cancer cells both in vitro and in vivo, with ongoing preclinical studies in collaboration with the University of Alabama at Birmingham.

Led by a team of accomplished scientists and innovators, including Dr. Jonathan Lindsey and Dr. Suzanne Lapi, Oncurie is dedicated to advancing the next generation of radiopharmaceuticals. With significant funding support and a commitment to research and development, the company aims to enhance diagnostic imaging and therapeutic options for ovarian cancer patients.

Generated from the website